Health‐related quality of life in Huntington's disease: Which factors matter most?
The DOI matches its Crossref record.
Abstract
The aim of this article was to determine which aspects of Huntington's disease (HD) are most important with regard to the health‐related quality of life (HrQOL) of patients with this neurodegenerative disease. Seventy patients with HD participated in the study. Assessment comprised the Unified Huntington's Disease Rating Scale (UHDRS) motor, cognitive and functional capacity sections, and the Beck Depression inventory. Mental and physical HrQOL were assessed using summary scores of the SF‐36. Multiple regression analyses showed that functional capacity and depressive mood were significantly associated with HrQOL, in that greater impairments in HrQOL were associated with higher levels of depressive mood and lower functional capacity. Motor symptoms and cognitive function were not found to be as closely linked with HrQOL. Therefore, it can be concluded that, depressive mood and greater functional incapacity are key factors in HrQOL for people with HD, and further longitudinal investigation will be useful to determine their utility as specific targets in intervention studies aimed at improving patient HrQOL, or whether other mediating variables. As these two factors had a similar association with the mental and physical summary scores of the SF‐36, this generic HrQOL measure did not adequately capture and distinguish the true mental and physical health‐related HrQOL in HD. © 2008 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 18
- 10.1016/j.brainresbull.2006.10.027 · DOI
- Bowling A, 1995, Measuring disease: a review of disease‐specific quality of life measurement scales
- 10.1348/135910702320645417 · DOI · Paper page
- 10.1080/14768320500456947 · DOI · Paper page
- 10.1207/S15327558IJBM0901_03 · DOI
- 10.1007/s11136-007-9194-4 · DOI
- 10.1002/mds.1056 · DOI
- Quarrell O, 1999, Huntington's disease: the facts
- 10.1002/mds.20208 · DOI
- 10.1002/mds.870110204 · DOI · Paper page
- 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
- 10.1136/bmj.306.6890.1437 · DOI · Paper page
- 10.1136/jnnp.69.3.308 · DOI · Paper page
- 10.1016/j.parkreldis.2004.12.005 · DOI · Paper page
- 10.1159/000098468 · DOI
- 10.1002/mds.21408 · DOI
- 10.1002/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-# · DOI · Paper page
- Ho AK, 2007, Development of a disease‐specific quality of life instrument for people with Huntington's disease: hearing what patients say, In the World Congress on Huntington's Disease, Dresden
Cited by
Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641
Tabrizi, S. J., Reilmann, R., Roos, R. A., Durr, A., Leavitt, B., Owen, G., Jones, R., Johnson, H., Craufurd, D., Hicks, S. L., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70263-0 · Cited by 547
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil-Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 269
Kayaalp, A., Page, K. J., & Rospenda, K. M. (2021) · Work & Stress · doi:10.1080/02678373.2020.1832609 · Cited by 177
Paulsen, J. S., Nance, M., Kim, J.-I., Carlozzi, N. E., Panegyres, P. K., Erwin, C., Goh, A., McCusker, E., & Williams, J. K. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.08.003 · Cited by 168
Aziz, N. A., Anguelova, G. V., Marinus, J., Lammers, G. J., & Roos, R. A. C. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.009 · Cited by 155
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy
Winter, Y., Schepelmann, K., Spottke, A. E., Claus, D., Grothe, C., Schröder, R., Heuss, D., Vielhaber, S., Tackenberg, B., Mylius, V., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5549-9 · Cited by 86
Psychological Interventions for People with Huntington’s Disease: A Call to Arms
Zarotti, N., Dale, M., Eccles, F., & Simpson, J. (2020) · Journal of Huntington's Disease · doi:10.3233/jhd-200418 · Cited by 59
Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington’s Disease
Fritz, N. E., Boileau, N. R., Stout, J. C., Ready, R., Perlmutter, J. S., Paulsen, J. S., Quaid, K., Barton, S., McCormack, M. K., Perlman, S. L., et al. (2018) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.17080173 · Cited by 56
Systematic review of pharmacological treatments for depressive symptoms in Huntington’s disease
Moulton, C. D., Hopkins, C. W. P., & Bevan‐Jones, W. R. (2014) · Movement Disorders · doi:10.1002/mds.25980 · Cited by 49
Clare, L., Teale, J. C., Toms, G., Kudlicka, A., Evans, I., Abrahams, S., Goldstein, L. H., Hindle, J. V., Ho, A. K., Jahanshahi, M., et al. (2019) · NeuroRehabilitation · doi:10.3233/nre-172353 · Cited by 37
Self-citationDisordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington’s Disease
Morris, L., O'Callaghan, C., & Le Heron, C. (2022) · Movement Disorders · doi:10.1002/mds.29013 · Cited by 36
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis
Jones, A. R., Jivraj, N., Balendra, R., Murphy, C., Kelly, J., Thornhill, M., Young, C., Shaw, P. J., Leigh, P. N., Turner, M. R., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.872149 · Cited by 35
Age of onset and behavioral manifestations in Huntington's disease: An Enroll‐HD cohort analysis
Ranganathan, M., Kostyk, S. K., Allain, D. C., Race, J. A., & Daley, A. M. (2021) · Clinical Genetics · doi:10.1111/cge.13857 · Cited by 20
Theed, R., Eccles, F. J. R., & Simpson, J. (2018) · Psychology and Psychotherapy: Theory, Research and Practice · doi:10.1111/papt.12157 · Cited by 19
Metadata
- Authors
- Ho, A. K., Gilbert, A. S., Mason, S. L., Goodman, A. O., & Barker, R. A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2009-03-15
- Volume
- 24
- Issue
- 4
- Pages
- 574-578
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1968164001
- Cited by
- 150
- References
- 0
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.